NEWARK, Del., July 11, 2026 — The global Healthcare CSF and Plasma Biomarker Market is poised for sustained expansion as precision medicine, neurological disease diagnostics, and personalized healthcare continue transforming clinical decision-making worldwide. According to Future Market Insights (FMI), the market is projected to grow from USD 3,229.4 million in 2026 to USD 6,655.8 million...